Mo1542: COMPARED EFFICACY OF USTEKINUMAB AND ANTI-TNF AGENTS AS FIRST-LINE BIOLOGICAL THERAPY IN LUMINAL CROHN’S DISEASE: A TWO-CENTER RETROSPECTIVE STUDY.
Authors:
- Pauline RivièrePRPauline Rivière
- Caitlyn KantersCKCaitlyn Kanters
- Alexander NiANAlexander Ni
- Gauthier PelletGPGauthier Pellet
- Marianne HupéMHMarianne Hupé
- Nesrine AboulhamidNANesrine Aboulhamid
- Florian PoullenotFPFlorian Poullenot
- Alain BittonABAlain Bitton
- Frank ZerbibFZFrank Zerbib
- Peter L. LakatosPeter L. Lakatos
- Waqqas AfifWAWaqqas Afif
- David LaharieDLDavid Laharie
- 16 June 2022
- journal article
- abstracts
- Published by Elsevier in Gastroenterology
- Vol. 162 (7)